Liposuction in Colombia
Liposuction in Colombia section, includes general infrmation about Liposuction Procedure, Liposuction Colombia Local News, Liposuction Colombia Surgeon Locator and other Liposuction related material.
Liposuction Procedure
The procedure can "sculpture " your body by removing extra fat from tummy, buttocks, arms, knees, cheeks and neck.. You must remember that liposuction is not an alternative for diet and exercise, it's main target is to help remove extra fat from areas in which fat reduction cannot be done successfully by dieting.
The ideal candidates for the surgery are people with normal weight, elastic skin and areas of "fat pockets" in their body. There are no age limits but older people has less elastic skin and therefore might get results that are worse then the younger patients.
Liposuction can be done by several techniques: solution injection - in which the surgeon injects a special solution to the fat tissue. The solution consists of anesthetics to reduce pain. Adrenalin to reduce bleeding and fluid to help separate the fat from the tissue.
The tumescent technique - much larger amounts of solution is being injected. Surgeons use this method, which allows to inject large amounts of anesthetics, and therefore this kind of procedure can be done with local anesthetics. The operation usually takes longer than the first one (4-5 hours).
The super wet technique in which the amount of solution injected equals the amount of fat tissue removed. This method also takes longer time and has to be done with general anesthetics.
Ultrasound assisted lipoplasty is another technique in which sound waves targeted to fat tissue. The waves break the connection between the fat cells, which are then being removed by suction. This method can be used in areas with connective tissue like the back and male breasts and also in areas that require more precise suction.
After the surgery to avoid swelling the areas of the suction will have elastic bandages. The surgeon may also leave draining tubes to prevent fluid collection. You might also receive antibiotics to prevent an infection.
Every surgery has its complications. In liposuction of 5 liter of fat and more there is a risk of fat or clot emboli to the lungs and even death. Extra fluids might be difficult to remove. The suction tube may cause skin necrosis or alter sensation in the area due to nerve damage. The ultrasound technique regarded as relatively safe produces, but it is a new one therefore the long term damage still unknown. In general, the surgery presents an extra rick for patients with diabetes, lung and heart disease and for those who had similar procedure in the past.
Other Liposuction Procedures
All Body Procedures
Liposuction Colombia (current)
Liposuction Colombia Buttock Augmentation
Liposuction Colombia Calf Augmentation
Liposuction Colombia Liposuction
Liposuction Colombia Body Contouring
More Colombia info...
Colombia Other destinations
San Agust?n and Tierradentro - archeological sites in south-western Colombia
Isla Gorgona - This former prison island in the Pacific Ocean is now a nature reserve open for visitors. There is abundant wildlife like monkeys, snakes, whales and sea turtles. It offers excellent diving conditions.
Ciudad Perdida is pre-Columbian city located in the Colombian jungle close to Santa Marta. Built between the eighth and the fourteenth century by the Tayrona Indians. Nowadays only stone circular shaped terraces covered by jungle remain.
Colombia History Colombia became independent from Spain in 1819. It was one of the five countries liberated by Simon Bolivar (the others being Ecuador, Venezuela, Peru and Bolivia). Colombia, Ecuador, Venezuela and Panama then formed the first Republic of Colombia. Ecuador and Venezuela declared their independence from Colombia in 1830. Panama declared its independence from Colombia in 1903 with the support of the United States of America. A 40-year communist insurgent campaign to overthrow the Colombian Government escalated during the 1990s, under girded in part by funds from the drug trade. Although the violence is deadly and large swaths of the rural countryside are under guerrilla influence, the movement lacks the military strength or popular support necessary to overthrow the government. Illegal anti-insurgent paramilitary groups have grown to be several thousand strong in recent years, challenging the insurgents for control of territory and illicit industries such as the drug trade and also the government's ability to exert its dominion over rural areas. While Bogot? continues to try to negotiate a settlement, neighboring countries worry about the violence spilling over their borders.
LiposuctionLatest Forum Posts...
- Hello! I have friends whose daughters are getting so interested in lipo. Does anyone know if there is any age requirement for lipo? Is it safe for younger people? Thanks!
Plastic Surgery News...
- In a new study commissioned by the American Society for Aesthetic Plastic Surgery (ASAPS) and released today, men and women ages 18-24 had the highest approval rating for cosmetic surgery. "It makes sense that young people are the most approving of plastic surgery. Twenty years ago people thought only movie stars and rich women had plastic surgery," said Foad Nahai, MD, president of ASAPS. (Source: Cosmetic Medicine / Plastic Surgery News From Medical News Today)
Context Abdominal obesity is associated with metabolic abnormalities and increased risk of atherosclerotic cardiovascular disease. However, no obesity management strategy has demonstrated the ability to slow progression of coronary disease.
Objective To determine whether weight loss and metabolic effects of the selective cannabinoid type 1 receptor antagonist rimonabant reduces progression of coronary disease in patients with abdominal obesity and the metabolic syndrome.
Design, Setting, and Patients Randomized, double-blinded, placebo-controlled, 2-group, parallel-group trial (enrollment December 2004-December 2005) comparing rimonabant with placebo in 839 patients at 112 centers in North America, Europe, and Australia.
Interventions Patients received dietary counseling, were randomized to receive rimonabant (20 mg daily) or matching placebo, and underwent coronary intravascular ultrasonography at baseline (n = 839) and study completion (n = 676).
Main Outcome Measures The primary efficacy parameter was change in percent atheroma volume (PAV); the secondary efficacy parameter was change in normalized total atheroma volume (TAV).
Results In the rimonabant vs placebo groups, PAV (95% confidence interval [CI]) increased 0.25% (–0.04% to 0.54%) vs 0.51% (0.22% to 0.80%) (P = .22), respectively, and TAV decreased 2.2 mm3 (–4.09 to –0.24) vs an increase of 0.88 mm3 (–1.03 to 2.79) (P = .03). In the rimonabant vs placebo groups, imputing results based on baseline characteristics for patients not completing the trial, PAV increased 0.25% (–0.04% to 0.55%) vs 0.57% (0.29% to 0.84%) (P = .13), and TAV decreased 1.95 mm3 (–3.8 to –0.10) vs an increase of 1.19 mm3 (–0.73 to 3.12) (P = .02). Rimonabant-treated patients had a larger reduction in body weight (4.3 kg [–5.1 to –3.5] vs 0.5 kg [–1.3 to 0.3]) and greater decrease in waist circumference (4.5 cm [–5.4 to –3.7] vs 1.0 cm [–1.9 to –0.2]) (P < .001 for both comparisons). In the rimonabant vs placebo groups, high-density lipoprotein cholesterol levels increased 5.8 mg/dL (4.9 to 6.8) (22.4%) vs 1.8 mg/dL (0.9 to 2.7) (6.9%) (P < .001), and median triglyceride levels decreased 24.8 mg/dL (–35.4 to –17.3) (20.5%) vs 8.9 mg/dL (–14.2 to –1.8) (6.2%) (P < .001). Rimonabant-treated patients had greater decreases in high-sensitivity C-reactive protein (1.3 mg/dL [–1.7 to –1.2] [50.3%] vs 0.9 mg/dL [–1.4 to –0.5] [30.9%]) and less increase in glycated hemoglobin levels (0.11% [0.02% to 0.20%] vs 0.40% [0.31% to 0.49%]) (P < .001 for both comparisons). Psychiatric adverse effects were more common in the rimonabant group (43.4% vs 28.4%, P < .001).
Conclusions After 18 months of treatment, the study failed to show an effect for rimonabant on disease progression for the primary end point (PAV) but showed a favorable effect on the secondary end point (TAV). Determining whether rimonabant is useful in management of coronary disease will require additional imaging and outcomes trials, which are currently under way.
Trial Registration clinicaltrials.gov Identifier: NCT00124332
Published online April 1, 2008 (doi:10.1001/jama.299.13.1547).